HEPACAM and myeloid sarcoma: More recently, this potential role of B cells has regained attention in the context of the association between Epstein–Barr virus and MS, with cross-reactive antibodies between EBNA1 and GlialCAM, ANO2, and CRYAB proposed to develop via molecular mimicry [85].